Ankyra Therapeutics Announces $45 Million Series B Financing And Appoints Howard L. Kaufman M.D. As Chief Medical Officer
Amount Raised
$45 Million
Round Type
Series B
CambridgeBiotechnologyHealthcareSoftwareDescription
Ankyra Therapeutics, a company developing cancer therapies based on tumor localized immune potentiating agents that boost anti-tumor immune responses, today announced the closing of a $45 million Series B financing. Proceeds from the financing will be used to progress Ankyra’s lead molecule, ANK-101 through Investigational New Drug (IND) enabling studies and into Phase 1 clinical trials, as well as advance additional cytokine programs.
Quick answer
Ankyra Therapeutics raised $45 Million in a Series B round, dated November 12, 2021. Ankyra Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Ankyra Therapeutics raise?
- Ankyra Therapeutics raised $45 Million in a Series B round on November 12, 2021.
- What does Ankyra Therapeutics do?
- Ankyra Therapeutics is a biotechnology company that has developed a highly differentiated technology platform that expands the therapeutic window of therapeutic drugs by forming a stable depot after local administration..
- Where is Ankyra Therapeutics based and how big is it?
- Ankyra Therapeutics is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Ankyra Therapeutics?
- Fundz holds 1 contact at Ankyra Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Ankyra Therapeutics, and when
A new round usually means Ankyra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ankyra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ankyra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ankyra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ankyra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAnkyra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.